Discussão de especialistas
Dar prioridade à OCT pós-COVID-19
10 junho 2020
· 50 MIN VISUALIZAÇÃO
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.100.100.file/dr-ike-ahmed.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.360.360.file/dr-ike-ahmed.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.768.768.file/dr-ike-ahmed.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/dr-ike-ahmed.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg"})
Autor
Ike Ahmed, MD
Prism Eye Institute, Canadá
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.100.100.file/schlenker-m.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.360.360.file/schlenker-m.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.768.768.file/schlenker-m.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/schlenker-m.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg"})
Autor
Matt Schlenker, MD
Kensington Eye Institute, Canadá
RESUMO
Dar prioridade à OCT e utilizá-la no tratamento do glaucoma pós-COVID-19
Este debate oportuno conta com a participação dos especialistas Ike Ahmed, MD e Matt Schlenker, MD, que partilham as suas ideias sobre a melhor forma de tratar os pacientes com glaucoma e dar prioridade à OCT após a COVID-19. Na altura em que é possível ter vários pacientes a regressar ao consultório para fazer consultas/exames presenciais, sugerem que se tenha em conta 4 aspetos:
- Como avaliar os pacientes com glaucoma através da teleoftalmologia
- Compreender as formas mais eficientes de avaliação utilizando imagens, tendo em conta a correlação da função estrutural
- Tirar partido de impressões únicas para avaliação de doenças e identificação de artefactos
- O valor da análise da progressão pós-COVID-19
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.100.56.0,0,1829,1029.file/preview-image.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.360.203.0,0,1829,1029.file/preview-image.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.768.432.0,0,1829,1029.file/preview-image.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.1024.576.0,0,1829,1029.file/preview-image.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.1280.720.0,0,1829,1029.file/preview-image.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.1440.810.0,0,1829,1029.file/preview-image.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/262-oct-for-manging-glaucoma/image/preview-image.png/_jcr_content/renditions/original.image_file.1829.1029.0,0,1829,1029.file/preview-image.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.100.56.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.360.203.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.745.419.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.745.419.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.745.419.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.745.419.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/122-data-integration-for-clinical-decision-making1/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg/_jcr_content/renditions/original.image_file.745.419.0,0,745,419.file/karth-whitepaper-zeiss-idi-en-31_021_0015i_overview.jpg"})